Orion, Orion Pharma
Orion, Orion Pharma is a Finland-based pharmaceutical company running 4 late-stage cancer trials of ODM-212, ODM-216 and sotorasib in mesothelioma, pancreatic ductal adenocarcinoma and non-small-cell lung cancer.
Overview
Orion, Orion Pharma, based in Espoo, Finland, is a pharmaceutical company. Orion Pharma is a Finnish pharmaceutical company that develops and manufactures medicines across oncology, respiratory disease, neurological disease, women's health and pain management, as well as veterinary medicines and active pharmaceutical ingredients. On ClinicalTrials.gov it is the lead sponsor of 4 recruiting or active phase 2 and phase 3 interventional cancer trials, testing ODM-212, ODM-216, sotorasib and ODM-208 in mesothelioma, pancreatic ductal adenocarcinoma, non-small-cell lung cancer and prostate cancer. The largest, NCT06725758 (A Phase 1/2, First-in-Human Study On ODM-212 In Subjects With Selected Advanced Solid Tumours), plans to enrol 315 participants. Sponsor and trial facts are from the ClinicalTrials.gov registry, checked on 2026-09-11; company facts are from the official website.
Similar pages
not linked directly; found by shared links- CompanyMBrace Therapeutics
Shares Pancreatic ductal adenocarcinoma, Prostate cancer, Non-small-cell lung cancer and the tag ctgov-sponsor.
- CompanyCivaTech Oncology
Shares Pancreatic ductal adenocarcinoma, Non-small-cell lung cancer and the tag ctgov-sponsor.
- CompanyShenzhen Ionova Life Sciences
Shares Pancreatic ductal adenocarcinoma, Prostate cancer, Non-small-cell lung cancer and the tag ctgov-sponsor.
- CompanyMolecular Partners
Shares Pancreatic ductal adenocarcinoma, Non-small-cell lung cancer and the tag ctgov-sponsor.
- CompanyCEBIOTEX
Shares Pancreatic ductal adenocarcinoma and the tag ctgov-sponsor.
- CompanyFutureChem
Shares Prostate cancer and the tag ctgov-sponsor.
- CompanyHinova Pharmaceuticals
Shares Prostate cancer and the tag ctgov-sponsor.
- CompanySpectraCure
Shares Prostate cancer and the tag ctgov-sponsor.